about
HLA-dependent tumour development: a role for tumour associate macrophages?HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Clinical and biological significance of HLA-G expression in ovarian cancerSoluble HLA-G: Are they clinically relevant?Polymorphic variants in exon 8 at the 3' UTR of the HLA-G gene are associated with septic shock in critically ill patientsTumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.HLA-G expression in hematologic malignancies.Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages.Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis.HLA-G levels in serum and plasma.Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: does it have a prognostic value?HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma
P2860
Q27022124-2A14DC02-F615-499A-9CE5-1410FD943A15Q33558697-A55B193B-C8AC-4D54-B0D1-58115A765D44Q36184793-B4DBAA43-C957-4B54-B1FB-E7BE06EB5E6AQ36296442-95A0D4F0-784A-47E0-ADDC-BE4330B63B19Q36384011-39AE97E5-7BE6-4FA7-96DA-A7532D36380CQ36928286-06927A53-36BE-4665-AA42-DAFD732088F3Q37242917-4D12A3D1-0C2C-4D6F-A9EF-4BA617548E9BQ37293938-976B592D-DF81-472E-98F3-1753657BF433Q37294991-8896A2F3-27BB-445C-9E11-CC46B9AF7492Q37406706-1FFC9DC3-8585-4171-9B40-454E8EFC1178Q37810072-07D70773-707C-44D9-B9D1-75B7A4834C6AQ40293176-BB21C5E2-DD8C-4BE5-BBCB-CCC633FBD1F3Q44838586-D701DB73-B650-4EE5-AEA1-79808956C2FFQ46915117-AE8CA9E8-DE22-4000-A733-79E3565C2320Q53535349-2C26887D-6699-453A-94D7-EC842FB64E23Q57272184-B4140E13-EA10-4D4D-842E-2EC39E63ADC9
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
HLA-G and lymphoproliferative disorders.
@ast
HLA-G and lymphoproliferative disorders.
@en
type
label
HLA-G and lymphoproliferative disorders.
@ast
HLA-G and lymphoproliferative disorders.
@en
prefLabel
HLA-G and lymphoproliferative disorders.
@ast
HLA-G and lymphoproliferative disorders.
@en
P2093
P50
P1476
HLA-G and lymphoproliferative disorders.
@en
P2093
Bernard Drénou
Gaëlle Le Friec
Laurence Amiot
Marc Bernard
Renée Fauchet
Valérie Guilloux
P304
P356
10.1016/S1044-579X(03)00029-4
P577
2003-10-01T00:00:00Z